868-68-8 Usage
General Description
Diethyl 2,6-dibromoheptanedioate is a chemical compound with the molecular formula C11H16Br2O4. This organic substance is part of the class of compounds known as dibromobenzenes. Dibromobenzenes are organobromine compounds that contain exactly two bromine atoms attached to a benzene ring. In addition to its chemical formula, other key properties include a molecular weight of approximately 402.04 g/mol and a heavy atom count of 17. The compound comes as a clear liquid and is primarily used in various industrial applications and in chemical research or synthesis. Overall, like any other chemical substance, it is essential to handle Diethyl 2,6-dibromoheptanedioate with care due to potential safety hazards.
Check Digit Verification of cas no
The CAS Registry Mumber 868-68-8 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 8,6 and 8 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 868-68:
(5*8)+(4*6)+(3*8)+(2*6)+(1*8)=108
108 % 10 = 8
So 868-68-8 is a valid CAS Registry Number.
InChI:InChI=1/C11H18Br2O4/c1-3-16-10(14)8(12)6-5-7-9(13)11(15)17-4-2/h8-9H,3-7H2,1-2H3
868-68-8Relevant articles and documents
NOVEL DIAZABICYCLIC ARYL DERIVATIVES AND THEIR MEDICAL USE
-
Page/Page column 20, (2010/11/27)
This invention relates to novel diazabicyclic aryl derivatives, which are found to be cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.